Biocon Surges After Syngene Gets Sebi Nod for IPO

By Religare
Subscribe to GoodReturns
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

    Shares of Biocon rose over 2 per cent in early trade on Bombay Stock Exchange (BSE) after Syngene International, research arm of biotechnology major received Securities Exchange Board of India's (Sebi) approval to launch an initial public offer (IPO).

    Biocon Surges After Syngene Gets Sebi Nod for IPO

    As per the draft papers, Syngene International plans to sell 22 million equity shares, including reservation of up to two million shares for Biocon shareholders, through an offer for sale.

    Cheering the development, shares of company surged 2.03 per cent in intra-day trade to quote at Rs 455.95 apiece on the BSE.

    In a similar trend, shares of the company gained 2.12 per cent to trade at Rs 456 a piece on National Stock Exchange.

    Meanwhile, the broader benchmark BSE Sensex was trading at 26,494.83, down 91.72 points, or 0.34 per cent at 11.11 hours.

    Read more about: biocon
    Company Search
    Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

    Find IFSC

    Get Latest News alerts from Goodreturns

    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more